Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 2.12.2024B.Braun Melsungen AG (BME)13892Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 20x100 ml (fľ.PE))2.12.2024O
 2.12.2024Orion Corporation (ORN)5969EFrimig Duo 85 mg/500 mg filmom obalené tablety (tbl flm 9x85 mg/500 mg (blis.PVC/Al/OPA/Al))20.11.2024U
 2.12.2024B.Braun Melsungen AG (BME)13897Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x250 ml (fľ.PE))2.12.2024O
 2.12.2024B.Braun Melsungen AG (BME)0019AParacetamol B. Braun 10 mg/ml (sol inf 10x100 ml/1000 mg (fľ.LDPE))2.12.2024O
 2.12.2024B.Braun Melsungen AG (BME)76566Metronidazol B. Braun 5 mg/ml (sol inf 20x100 ml/500 mg (fľ. PE))2.12.2024O
 2.12.2024B.Braun Melsungen AG (BME)13907Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x1000 ml (fľ.PE))2.12.2024O
 2.12.2024BELUPO, s.r.o. (BLU-SK)58308Afloderm (crm der 1x20 g (tuba Al))2.12.2024R
 2.12.2024medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)8877AMetoject PEN 7,5 mg injekčný roztok naplnený v injekčnom pere (sol ira 6x0,15 ml/7,5 mg (pero napl. BD))31.12.2024Z
 2.12.2024medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)8899AMetoject PEN 12,5 mg injekčný roztok naplnený v injekčnom pere (sol ira 6x0,25 ml/12,5 mg (pero napl. BD))31.12.2024Z
 2.12.2024medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)8921AMetoject PEN 17,5 mg injekčný roztok naplnený v injekčnom pere (sol ira 6x0,35 ml/17,5 mg (pero napl. BD))31.12.2024Z
 2.12.2024Desitin Arzneimitttel GmbH (DET)84449LUMINAL (sol inj 5x1 ml/200 mg (amp.skl.))2.12.2024O
 29.11.2024Zentiva, k.s. (ZNT-1)5784EDaroxomb 110 mg (cps dur 60x1x110 mg (blis.Al/OPA/Al/PVC - jednotk.bal.))25.11.2024U
 29.11.2024KRKA, d.d., Novo mesto (KRK-2)6039ETolvecamo 40 mg/5 mg/12,5 mg tablety (tbl 28x40 mg/5 mg/12,5 mg tablety (blis.OPA/Al/PVC//Al - kalend.bal.))25.11.2024U
 29.11.2024KRKA, d.d., Novo mesto (KRK-2)6048ETolvecamo 80 mg/5 mg/12,5 mg tablety (tbl 28x80 mg/5 mg/12,5 mg tablety (blis.OPA/Al/PVC//Al - kalend.bal.))25.11.2024U
 29.11.2024KRKA, d.d., Novo mesto (KRK-2)6056ETolvecamo 80 mg/10 mg/12,5 mg tablety (tbl 28x80 mg/10 mg/12,5 mg tablety (blis.OPA/Al/PVC//Al - kalend.bal.))25.11.2024U

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)